A measure to delay the unpopular "Cadillac tax," part of President Obama's health reform law, overwhelmingly passed the Senate by a 90-10 vote on Thursday.
A measure to delay the unpopular “Cadillac tax,” part of President Obama’s health reform law, overwhelmingly passed the Senate by a 90-10 vote on Thursday.
However, the overall bill, which would repeal other parts of the Affordable Care Act, will not become law: the president has already said he will veto the bill when it lands on his desk.
A statement released by the White House said, in no uncertain terms, “If the President were presented with H.R. 3762, as amended by the Senate amendment, he would veto the bill.”
The Senate received strong bipartisan support for the bill, which was amended by the Senate to include a delay of the Cadillac tax. The overall bill would phase out Medicaid expansion, defund Planned Parenthood, get rid of the medical device tax, and eliminate the subsidies that help consumers buy insurance.
“Americans are living with the consequences of this broken law and its broken promises every day,” US Senate Majority Leader Mitch McConnell said on the Senate floor before the vote. “Its negative effects are often felt in the most personal and visceral ways. And Americans are tired of being condescended to. They want change and they want a bridge to better care, not Obamacare.”
Regardless of the support the bill garnered, the Obama administration is not willing to let the president’s landmark law be unraveled.
“By repealing numerous, key elements of current law, this legislation would take away critical benefits and health care coverage from hard-working middle-class families,” the White House released in a statement. “The bill also would remove policies that are expected to help slow the growth in health care costs and that have improved the quality of care patients receive.”
Even though H.R. 3762 will ultimately be vetoed, there are ongoing talks to handle the Cadillac tax in other ways, according to The Hill. One possibility is to modify the tax as part of the end-of-year package of tax breaks.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More